If you want to actively support liver function after illness, medication, or prolonged stress, IV delivery ensures therapeutic levels reach the liver directly
This allows for greater spontaneity compared to some oral sexual health medications
2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association
The injectable obesity medications Semaglutide 2.4 mg, a selective GLP-1 receptor agonist, produces robust and durable weight loss of approximately 1516% over 68 weeks ( Tirzepatide, a dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonist, delivers even greater weight loss, exceeding 20% at the highest dose in pivotal trials ( Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies ( Survodutide, an oxyntomodulin analogue, achieved clinically meaningful weight loss ( Table 2
If microdosing is where your questions are, I go deeper in my article on GLP-1 microdosing for inflammatory arthritis